The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans for the next three months.
By Maria Cheng, Associated Press, Marilynn Marchione, AP Chief Medical Writer
Gilead said a government-run study of remdesivir, perhaps the most closely watched experimental drug to treat Covid-19, showed the medicine is effective.
By Matthew Herper, Adam Feuerstein, STAT News
The Trump administration’s new deal to provide uninsured Americans with free drugs to prevent HIV infection could be a promising step, but actually reaching the very people most in need -- and convincing them to take it -- will be…
By Jason Kane
WASHINGTON — A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.
By Ricardo Alonso-Zaldivar, Associated Press
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.